| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,449,000 | 1,504,300 | 1,203,900 | 1,451,500 | | Cost of Revenue | 906,400 | 946,000 | 781,100 | 1,016,700 | | | Gross Profit | 542,600 | 558,300 | 422,800 | 434,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 350,300 | 329,300 | 311,500 | 354,500 | | Non Recurring | 27,000 | 29,500 | 30,500 | 318,400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 165,300 | 199,500 | 80,800 | (238,100) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (600) | (1,200) | (700) | 4,200 | | Earnings Before Interest And Taxes | 58,100 | 198,300 | 80,100 | (233,900) | | Interest Expense | (70,900) | 40,300 | 30,600 | 43,500 | | Income Before Tax | 129,000 | 158,000 | 49,500 | (277,400) | | Income Tax Expense | 43,500 | 52,300 | 15,800 | (20,700) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 85,500 | 105,700 | 33,700 | (256,700) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 85,500 | 105,700 | 33,700 | (256,700) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $85,500 | $105,700 | $33,700 | ($256,700) |
|
1.00% Nasdaq 
Income Statement
